3

FORM 3 SUBMISSION

Company: RECURSION PHARMACEUTICALS, INC.
Filed: April 15, 2021
Period of Report: April 15, 2021
Accession Number: 0001209191-21-026778

View Document ↗ View on SEC.gov ↗